PeptideDB

CK7 507487-89-0

CK7 507487-89-0

CAS No.: 507487-89-0

CK7, a Cdk2/9 inhibitor, may be utilized to prepare the Nek1 inhibitors BSc5231 and BSc5367.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CK7, a Cdk2/9 inhibitor, may be utilized to prepare the Nek1 inhibitors BSc5231 and BSc5367.

Physicochemical Properties


Molecular Formula C14H12N6O2S
Molecular Weight 328.35
Exact Mass 328.074
CAS # 507487-89-0
PubChem CID 447961
Appearance Light yellow to yellow solid powder
LogP 3.668
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 3
Heavy Atom Count 23
Complexity 423
Defined Atom Stereocenter Count 0
InChi Key DYTKVFHLKPDNRW-UHFFFAOYSA-N
InChi Code

InChI=1S/C14H12N6O2S/c1-8-12(23-13(15)17-8)11-5-6-16-14(19-11)18-9-3-2-4-10(7-9)20(21)22/h2-7H,1H3,(H2,15,17)(H,16,18,19)
Chemical Name

4-methyl-5-[2-(3-nitroanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets CDK2 CDK9
References

[1]. Design, synthesis and biological evaluation of novel aminopyrazole- and 7-azaindole-based Nek1 inhibitors and their effects on zebrafish kidney development. Bioorg Med Chem Lett. 2021;53:128418.


Solubility Data


Solubility (In Vitro) DMSO : 12.5 mg/mL (38.07 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (6.33 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0455 mL 15.2277 mL 30.4553 mL
5 mM 0.6091 mL 3.0455 mL 6.0911 mL
10 mM 0.3046 mL 1.5228 mL 3.0455 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.